TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ)
$4.06 -0.02 (-0.4902%)
Analysed TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) News Sources
Treace Medical Concepts Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
Treace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
09-05-2026
yahoo.com
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
13-05-2026
yahoo.com
Treace Medical (TMCI) Q1 2026 Earnings Transcript
01-06-2026
fool.com
Treace Medical (TMCI) Q4 2025 Earnings Transcript
01-06-2026
fool.com
June 2026's Top Penny Stocks To Watch
11-06-2026
yahoo.com
Treace to Present at the Sidoti Small Cap Conference
11-06-2026
yahoo.com
Sidoti Events, LLC's June Small-Cap Virtual Conference
16-06-2026
yahoo.com
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
18-06-2026
yahoo.com
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
24-07-2026
yahoo.com
What is the current price of TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ)?
The current price of TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) is $4.06.
TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) absolute price change since previous trading day?
The absolute price change of TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) since the previous trading day is $-0.02.
TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) percentage price change since previous trading day?
The percentage price change of TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) since the previous trading day is -0.4902%.
What is the most recent average sentiment score for TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ)?
The most recent average sentiment score for TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ)?
The most recent sentiment for TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ) is .
SEC-8K** Filing Available For TREACE MEDICAL CONCEPTS INC (TMCI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.